One patient with metastatic NSCLC passed away (Grade 5) due to pneumonia/lung infection that was determined by the investigator to be possibly related to BLU-667.
What impact, if any, do you see this having on the prospects for ultimate approval for BLU-667?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.